- $49.49bn
- $51.68bn
- $6.95bn
Media: Agilent buys medical instruments maker Biocare for $950 million - Bloomberg News
U.S. RESEARCH ROUNDUP-Arcellx, Costar Group, Magnite
Agilent Q1 revenue slightly misses estimates
Agilent reports in-line first quarter, says results hurt by US snowstorm
Brief: Agilent Q1 Revenue USD 1,798 Million Vs. IBES Estimate USD 1,807 Million
Keysight forecasts quarterly profit above estimates on strong data center-led demand
Brief: Agilent Presents Boehringer Ingelheim With Inaugural 2025 Instrument Trade‑In Impact Award
Brief: Agilent Receives FDA Approval For Pd-L1 Ihc 22C3 Pharmdx In Epithelial Ovarian, Fallopian Tube, Or Primary Peritoneal Carcinoma (Eoc)
Brief: FDA Approves Pembrolizumab With Paclitaxel For Platinum-Resistant Epithelial Ovarian, Fallopian Tube, Primary Peritoneal Carcinoma
U.S. RESEARCH ROUNDUP-Alphabet, Micron Technology, Microsoft
Brief: Agilent Announces 21 Cfr Part 11 Compliance Software For Xcelligence RTCA eSight
U.S. RESEARCH ROUNDUP-Air Products, Hanover Insurance, Kinsale Capital
Keysight beats quarterly forecast estimates on strong demand from AI data centers
Lab instruments maker Agilent's Q4 revenue beats estimates
Brief: Agilent Q4 Revenue USD 1,861 Million Vs. IBES Estimate USD 1,832 Million
Brief: Agilent Technologies Posts Q4 Adj EPS $1.59 Vs IBES Estimate $1.58
Agilent beats quarterly revenue estimates on strong demand for lab tools
Brief: Agilent Names Adam S. Elinoff As Chief Financial Officer
U.S. RESEARCH ROUNDUP- Exxon Mobil, IQVIA Holdings, Oracle